CROS NT extends Datatrak Connect partnership
CROS NT, an international CRO based in Chapel Hill, N.C., is extending its partnership with Datatrak, a worldwide technology and services company, as part of its life science technology portfolio. The partnership allows CROS NT to provide Datatrak's Unified eClinical platform, which includes Electronic Data Capture (EDC), Clinical Trial Management System (CTMS), randomization and clinical trial supply management (RTSM), as well as a web-based patient diary (ePRO).
CROS NT joined Datatrak Connect Partner program to offer a unified, cloud-based technology solution to enhance the quality of clinical data in an efficient and convenient manner for both drug and device development companies. Since joining the program, CROS NT has implemented Datatrak's eClinical platform in a large number of studies across U.S. and Europe.
At the beginning of the year, Datatrak announced a new release of its Datatrak One unified platform with three applications now available to support individual or cross-study functionality:
- The Cross Study Manager enables real time data, analytics and reporting at the trial or cross-study level for over 100 fields
- The Scheduler delivers information to the appropriate person in an individual trial or across a program of studies
- File Versioning improves data quality with a unified view of files online in real time.
Paul Fardy, chief operations officer for CROS NT, said, "Our decision to extend our participation in the Datatrak Partner Program is a reflection of the success we've had in the past implementing the unified platform in some of our global studies as well as Datatrak's commitment to constantly improving the system's functionality to meet the increasing demands of sponsors for real-time data analysis and reporting capabilities."
Laurence P. Birch, chairman and CEO for Datatrak, said, "Our mutual success is driven by delivering a simplified eClinical platform that removes time consuming and costly complexity, including data integration and long wait times for cross-study reporting. We look forward to expanding our partnership with CROS NT in 2015 and beyond."